Innovation – Open view page
General information
| Innovation ID | 566 |
| Version ID | 436 |
| Innovation Title | Kabuli chickpea inbred variety NBeG 810 for cultivation in low altitude areas in India |
| Innovation description | NBeG 810 is an extra large seeded, and early maturing Kabuli chickpea with Fusarium wilt resistance. It is high-yielding (2.2 to 2.5 mt/ha) producing highly digestible grains high in iron, zinc, and protein. This variety will potentially contribute to SDG`s 1,2,3,7,8,10,11,12,13,15, and 17. |
| Reporting Staff | Srinivasan Samineni (ICRISAT) |
| Year (Reporting) | 2020 |
| Reporting status | Approved |
| Innovation Type | Genetic (variety and breeds) |
| Number of varieties | 1 |
Stage reached
| Stage of Innovation | Stage 3: available/ ready for uptake |
| Year (Stage) | 2020 |
| Stage Description | This variety is ready for uptake by farmers and was released on October 7, 2020 for cultivation in India particularly suitable for the west central zone and north west plain zone of India. |
| Has a lead organization | yes |
| Lead Organization | Acharya N.G. Ranga Agricultural University, Regional Agricultural Research Station |
| Top 5 contributors | International Crops Research Institute for the Semi-Arid Tropics; Indian Council of Agricultural Research |
Contributions and mapping
| All partners | |
| Main CRP | CGIAR Research Program on Grain Legumes and Dryland Cereals |
| Flagship project | FP4-Variety and Hybrid Development |
| Cluster | FP4-3-Product testing and release |
| Other CRPs-Flagships-Clusters |
Scope
| Geographic scope | National |
| Regions | |
| Countries | India |
Targeted outcomes
| Main Sub-IDO | Enhanced genetic gain |
| Other Sub-IDO | Closed yield gaps through improved agronomic and animal husbandry practices |
| Other Sub-IDO | Reduced production risk |
Evidences
| Evidences | List of varieties released by ICRISAT (GLDC-mapped) 2020 from MEASURE Platform [https://mel.cgiar.org/uploads/relatedfiles/jhF3fH3GLzIx9UvsOqbzlMPwA0MDgf.xlsx] |
Linked Elements
| Milestones | 6814-172-37920 - New suite of resilient varieties released by NARS partners. (Phase 1 investments start being released) |
| Outcome Impact Case |
| Policy |